Insider filing · EWTX
Marc Semigran
Chief Development Officer
profile →
Edgewise Therapeutics, Inc.
EWTX · Healthcare · 28 filings in 24 months
ticker →
Marc Semigran sold $830K of Edgewise Therapeutics (EWTX)
Executed Dec 24 2024, disclosed Dec 27 2024, 3 days later.
Value, as filed
$830K
27,980 sh × $29.66
Executed
Dec 24 2024
the trade date, as filed
Disclosed
Dec 27 2024
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMarc Semigran (Chief Development Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $830K of EWTX (27,980 sh × $29.66, as filed), executed Dec 24 2024.
The name
EWTXHealthcare · Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle dis…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→